Our therapy areas

Unlocking the power of what science can do

The path to new treatments

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Oncology; BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Infectious Disease, and Respiratory & Immunology); and Rare Disease.



An exciting pipeline

Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

183

projects in our pipeline

116

new molecular entities or major life-cycle management in Phase II or Phase III

21

new molecular entities in our late-stage pipeline

4

new molecular entities under review

Veeva ID: Z4-83158
Date of preparation: April 2026


What science can do

Our purpose is to push the boundaries of science to deliver life-changing medicines